Botulinum toxin therapy for skin disorders

Details for Australian Patent Application No. 2004296870 (hide)

Owner Allergan, Inc.

Inventors First, Eric R.

Agent Davies Collison Cave

Pub. Number AU-B-2004296870

PCT Pub. Number WO2005/056050

Priority 10/731,973 09.12.03 US

Filing date 8 December 2004

Wipo publication date 23 June 2005

Acceptance publication date 20 May 2010

International Classifications

A61K 38/48 (2006.01) Medicinal preparations containing peptides

Event Publications

6 July 2006 PCT application entered the National Phase

  PCT publication WO2005/056050 Priority application(s): WO2005/056050

20 May 2010 Application Accepted

  Published as AU-B-2004296870

16 September 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004296872-Pharmaceutical compounding systems and methods and information management system for same

2004296868-Methods for suppressing an immune response or treating a proliferative disorder